Astellas Names Head of Global R&D Operations

DEERFIELD, Ill., June 10 /PRNewswire/ -- Astellas Pharma Global Development
("APGD"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan,
announced today that Dr. Peter Carberry, has been hired as the senior vice
president and head of global development operations. Carberry is responsible
for enhancing the effectiveness and efficiency of the integrated global
operational platform including the data sciences and clinical operations
organizations.

"We are pleased that Peter has joined Astellas and we know that he will
contribute significantly to the development of innovative products," said Dr.
Steven Ryder, president of APGD. "Peter is one of several key hires at APGD
that were brought on to strengthen and accelerate our research and development
function."

Prior to joining Astellas, Carberry was the vice president of clinical
operations, development planning and performance analysis and the office of
international development at Genentech. In that role, Carberry developed a
global platform for the execution of non-clinical and clinical activities and
established many key relationships with company stakeholders. Previously,
Carberry was the senior vice president of global clinical operations at
Johnson & Johnson Pharmaceutical Research and Development. Dr. Carberry began
his industry career with Pharmacia at the Kalamazoo Research site where he
held positions of increasing responsibility across the development
organization. Carberry earned his M.D. at the University of Nairobi in Kenya
and completed his Post Doctoral Fellowship in Clinical Pharmacology at the
University of Texas. He earned his M.B.A. at Western Michigan University.

About Astellas
Astellas Pharma Global Development, located in Deerfield, Illinois, is a group
company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical
company dedicated to improving the health of people around the world through
the provision of innovative and reliable pharmaceutical products. The
organization is committed to becoming a global category leader in focused
areas by combining outstanding R&D and marketing capabilities. For more
information about Astellas Pharma Inc., please visit the website at
http://www.astellas.com/en/.

SOURCE Astellas Pharma Global Development

Jenny Keeney of Astellas US LLC, +1-847-317-5405